Low Malignant Potential Ovarian Cancer
Chemotherapy for Low Malignant Potential Ovarian CancerChemotherapy is a low malignant potential ovarian cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.
When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (this is called systemic chemotherapy). When chemotherapy is placed directly into the spinal column, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (this is called regional chemotherapy). The way the chemotherapy is given will depend on the type and stage of the cancer being treated.
Before starting treatment for low malignant potential ovarian cancer, patients may want to consider taking part in a clinical trial. A clinical trial is a research study that is meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment.
The prognosis and treatment options for low malignant potential ovarian cancer will depend on:
- The type of cancer
- The size of the tumor
- The patient's general health
- The stage of the cancer (whether it affects part of the ovary, involves the whole ovary, or has spread to other places in the body).
In most cases, low malignant potential ovarian cancer can be treated successfully because these tumors are usually found early. However, most women survive even advanced-stage low malignant potential ovarian cancer. Patients who do not survive usually die from complications of the disease (such as a small bowel obstruction) or the side effects of treatment, but rarely because the tumor has spread.